Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Dual IRE 1 RN ase functions dictate glioblastoma development

Open access
Lhomond, Stéphanie, Avril, Tony, Dejeans, Nicolas, Voutetakis, Konstantinos, Doultsinos, Dimitrios, McMahon, Mari, Pineau, Raphaël, Obacz, Joanna, Papadodima, Olga, Jouan, Florence, Bourien, Heloise, Logotheti, Marianthi, Jégou, Gwénaële, Pallares‐Lupon, Néstor, Schmit, Kathleen, Le Reste, Pierre‐Jean, Etcheverry, Amandine, Mosser, Jean, Barroso, Kim, Vauléon, Elodie, Maurel, Marion, Samali, Afshin, Patterson, John B, Pluquet, Olivier, Hetz, Claudio, Quillien, Véronique, Chatziioannou, Aristotelis, Chevet, Eric · 2018 · EMBO Molecular Medicine

Abstract

Proteostasis imbalance is emerging as a major hallmark of cancer, driving tumor aggressiveness. Evidence suggests that the endoplasmic reticulum (ER), a major site for protein folding and quality control, plays a critical role in cancer development. This concept is valid in glioblastoma multiform (GBM), the most lethal primary brain cancer with no effective treatment. We previously demonstrated that the ER stress sensor IRE1α (referred to as IRE1) contributes to GBM progression, through XBP1 mRNA splicing and regulated IRE1-dependent decay (RIDD) of RNA Here, we first demonstrated IRE1 signaling significance to human GBM and defined specific IRE1-dependent gene expression signatures that were confronted to human GBM transcriptomes. This approach allowed us to demonstrate the antagonistic roles of XBP1 mRNA splicing and RIDD on tumor outcomes, mainly through selective remodeling of the tumor stroma. This study provides the first demonstration of a dual role of IRE1 downstream signaling in cancer and opens a new therapeutic window to abrogate tumor progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/emmm.201707929

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 174

Metadata

Authors
Lhomond, S., Avril, T., Dejeans, N., Voutetakis, K., Doultsinos, D., McMahon, M., Pineau, R., Obacz, J., Papadodima, O., Jouan, F., Bourien, H., Logotheti, M., Jégou, G., Pallares‐Lupon, N., Schmit, K., Le Reste, P., Etcheverry, A., Mosser, J., Barroso, K., Vauléon, E., Maurel, M., Samali, A., Patterson, J. B., Pluquet, O., Hetz, C., Quillien, V., Chatziioannou, A., & Chevet, E.
Venue
EMBO Molecular Medicine
Published
2018-01-08
Volume
10
Issue
3
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2782992910
Cited by
174
References
3
FWCI
10.42
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dual IRE 1 RN ase functions dictate glioblastoma development. https://app.cochat.ai/papers/10.15252/emmm.201707929
The paper
Lhomond, S., Avril, T., Dejeans, N., Voutetakis, K., Doultsinos, D., McMahon, M., Pineau, R., Obacz, J., Papadodima, O., Jouan, F., Bourien, H., Logotheti, M., Jégou, G., Pallares‐Lupon, N., Schmit, K., Le Reste, P., Etcheverry, A., Mosser, J., Barroso, K., . . . Chevet, E. (2018). Dual IRE 1 RN ase functions dictate glioblastoma development. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201707929

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.